TrialBritish journal of cancer2020

Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).

Francesco Gelsomino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.